ATS 2017 International Conference - Mobile

P1294 An Open-Label, Phase II Study (PIPF-002) of the Safety of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis (IPF)

Tuesday

May

23

9:15 AM

4:15 PM

Type : Scientific Abstract

Speaker(s)

Mark H. Gotfried

Carlos E. Girod

Danielle E. Antin-Ozerkis

Adefowope Odueyungbo

Philip Hormel

Indiana Strombom

John L. Stauffer

Klaus-Uwe Kirchgassler

Maria L. Padilla

Content

Parent Sessions

C38 UNDERSTANDING THERAPEUTICS IN IPF...
05-23-2017 9:15 AM - 4:15 PM